Detalhe da pesquisa
1.
New insights into the burden and costs of multiple sclerosis in Europe: Results for Portugal.
Mult Scler
; 23(2_suppl): 143-154, 2017 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-28643585
2.
New insights into the burden and costs of multiple sclerosis in Europe: Results for the Netherlands.
Mult Scler
; 23(2_suppl): 117-129, 2017 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-28643595
3.
New insights into the burden and costs of multiple sclerosis in Europe: Results for Poland.
Mult Scler
; 23(2_suppl): 130-142, 2017 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-28643586
4.
New insights into the burden and costs of multiple sclerosis in Europe: Results for Italy.
Mult Scler
; 23(2_suppl): 104-116, 2017 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-28643600
5.
New insights into the burden and costs of multiple sclerosis in Europe: Results for Hungary.
Mult Scler
; 23(2_suppl): 91-103, 2017 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-28643591
6.
Second-line treatment persistence and costs among patients with immune-mediated rheumatic diseases treated with subcutaneous TNF-alpha inhibitors.
Rheumatol Int
; 37(12): 2049-2058, 2017 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-28975392
7.
Treatment persistence among patients with immune-mediated rheumatic disease newly treated with subcutaneous TNF-alpha inhibitors and costs associated with non-persistence.
Rheumatol Int
; 36(7): 987-95, 2016 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-26780533
8.
Baseline patient characteristics, incidence of CINV, and physician perception of CINV incidence following moderately and highly emetogenic chemotherapy in Asia Pacific countries.
Support Care Cancer
; 23(1): 263-72, 2015 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-25120009
9.
Increased cause-specific mortality in patients with mild and severe psoriasis: a population-based Swedish register study.
Acta Derm Venereol
; 95(7): 809-15, 2015 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-25766866
10.
Identifying Predictors of First-Line Subcutaneous TNF-Inhibitor Persistence in Patients with Inflammatory Arthritis: A Decision Tree Analysis by Indication.
Adv Ther
; 40(10): 4657-4674, 2023 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37599341
11.
Treatment Persistence in Patients Cycling on Subcutaneous Tumor Necrosis Factor-Alpha Inhibitors in Inflammatory Arthritis: A Retrospective Study.
Adv Ther
; 39(1): 244-255, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34480294
12.
Treatment patterns for advanced non-small cell lung cancer in the US: A systematic review of observational studies.
Cancer Treat Res Commun
; 33: 100648, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36270164
13.
Health-Care and Societal Costs Associated with Non-Persistence with Subcutaneous TNF-α Inhibitors in the Treatment of Inflammatory Arthritis (IA): A Retrospective Observational Study.
Adv Ther
; 39(6): 2468-2486, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-34751912
14.
Healthcare-Related Costs Associated with Switching Subcutaneous Tumor Necrosis Factor-α Inhibitor in the Treatment of Inflammatory Arthritis: a Retrospective Study.
Adv Ther
; 37(9): 3746-3760, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32647910
15.
Real-World Patient Experience of Switching Biologic Treatment in Inflammatory Arthritis and Ulcerative Colitis - A Systematic Literature Review.
Patient Prefer Adherence
; 14: 309-320, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32109997
16.
Retrospective observational cohort study on innovation in oncology and progress in survival: How far have we gotten in the two decades of treating patients with advanced non-small cell lung cancer as a single population?
PLoS One
; 15(5): e0232669, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32396541
17.
The value of persistence in treatment with subcutaneous TNF-alpha inhibitors for ankylosing spondylitis.
Eur J Health Econ
; 21(1): 45-54, 2020 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-31522361
18.
Real-world cost-effectiveness of targeted therapy in metastatic renal cell carcinoma in Sweden: a population-based retrospective analysis.
Cancer Manag Res
; 11: 1289-1297, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-30799955
19.
Lack of an association between the TGFBR1*6A variant and colorectal cancer risk.
Clin Cancer Res
; 13(12): 3748-52, 2007 Jun 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-17575241
20.
Persistence and costs with subcutaneous TNF-alpha inhibitors in immune-mediated rheumatic disease stratified by treatment line.
Patient Prefer Adherence
; 11: 95-106, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-28144130